Weaver Gregory L Insider Trades

Insider Trading History

Track insider trading activity for Weaver Gregory L. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Altimmune
Altimmune ALT
Chief Financial Officer
Holding Value $109k 38,078 shares
Last Trade
Apr 01, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$31.5k 10,000 shares
$3.15
$2.87
Altimmune
Altimmune ALT
Chief Financial Officer
Holding Value $80.6k 28,078 shares
Last Trade
Mar 06, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$17.7k 5,000 shares
$3.54
$2.87
Altimmune
Altimmune ALT
Chief Financial Officer
Holding Value $743k 259,000 shares
Last Trade
Feb 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.16M 259,000 shares
$4.46
$2.87
Altimmune
Altimmune ALT
Chief Financial Officer
Holding Value $319k 111,000 shares
Last Trade
Feb 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$495k 111,000 shares
$4.46
$2.87
Altimmune
Altimmune ALT
Chief Financial Officer
Holding Value $82.5k 28,750 shares
Last Trade
Nov 11, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$80.3k 18,750 shares
$4.28
$2.87
Altimmune
Altimmune ALT
Chief Financial Officer
Holding Value $66.2k 23,078 shares
Last Trade
Nov 11, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$24.3k 5,672 shares
$4.28
$2.87
Altimmune
Altimmune ALT
Chief Financial Officer
Holding Value $161k 56,250 shares
Last Trade
Nov 11, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$80.3k 18,750 shares
$4.28
$2.87
Altimmune
Altimmune ALT
Chief Financial Officer
Holding Value $479k 166,800 shares
Last Trade
Oct 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$646k 166,800 shares
$3.87
$2.87
Altimmune
Altimmune ALT
Chief Financial Officer
Holding Value $28.7k 10,000 shares
Last Trade
Mar 13, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$52k 10,000 shares
$5.20
$2.87
Altimmune
Altimmune ALT
Chief Financial Officer
Holding Value $646k 225,000 shares
Last Trade
Nov 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.65M 225,000 shares
$7.35
$2.87
Atossa Therapeutics
Atossa Therapeutics ATOS
Former Evp, Cfo, & Director
Holding Value $259 55 shares
Last Trade
Nov 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$32.5k 50,000 shares
$0.65
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
EVP & CFO
Holding Value $235k 50,055 shares
Last Trade
Jun 20, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$48.5k 50,000 shares
$0.97
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
EVP & CFO
Holding Value $12.2M 2,600,000 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.39M 2,600,000 shares
$0.92
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
Director
Holding Value $588k 125,000 shares
Last Trade
May 04, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$82.5k 125,000 shares
$0.66
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
Director
Holding Value $235k 50,000 shares
Last Trade
May 13, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$49.3k 50,000 shares
$0.99
$4.70
ATAI Life Sciences N.V.
ATAI Life Sciences N.V. ATAI
Chief Financial Officer
Holding Value $1.03M 228,000 shares
Last Trade
Mar 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.29M 228,000 shares
$5.65
$4.53
ATAI Life Sciences N.V.
ATAI Life Sciences N.V. ATAI
Chief Financial Officer
Holding Value $1.03M 228,000 shares
Last Trade
Mar 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.29M 228,000 shares
$5.65
$4.53
Atossa Therapeutics
Atossa Therapeutics ATOS
Director
Holding Value $505k 107,497 shares
Last Trade
Jul 02, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$307k 57,084 shares
$5.37
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
Director
Holding Value $774k 164,581 shares
Last Trade
Jul 02, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$618k 115,000 shares
$5.37
$4.70
ATAI Life Sciences N.V.
ATAI Life Sciences N.V. ATAI
Chief Financial Officer
Holding Value $21.1k 4,666 shares
Last Trade
Jun 22, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$87.8k 4,666 shares
$18.82
$4.53

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up